(Q34458465)

2 August 2017

1 reference

title

Underutilisation of ACE inhibitors in patients with congestive heart failure (English)

1 reference

2 August 2017

1 reference

congestive heart failure

1 reference

Bungard TJ

1

1 reference

2 August 2017

McAlister FA

series ordinal

2

1 reference

2 August 2017

Johnson JA

series ordinal

3

1 reference

2 August 2017

Tsuyuki RT

series ordinal

4

1 reference

2 August 2017

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

61

1 reference

2 August 2017

14

1 reference

2 August 2017

2021-2033

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161140-00002

2 August 2017

0 references

cites work

Prevention of hospitalizations for heart failure with an interactive home monitoring program

1 reference

12 December 2020

Economic impact of heart failure in the United States: time for a different approach

1 reference

12 December 2020

The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology

1 reference

12 December 2020

Managing heart failure in a specialist clinic.

1 reference

12 December 2020

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

1 reference

12 December 2020

Diagnosis and management of heart failure. Canadian Cardiovascular Society

1 reference

12 December 2020

National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.

1 reference

12 December 2020

Epidemiology of congestive heart failure: Canadian data from 1970 to 1989.

1 reference

12 December 2020

Effect of improved disease management strategies on hospital length of stay in the treatment of congestive heart failure

1 reference

12 December 2020

Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

12 December 2020

Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure

1 reference

12 December 2020

The pharmacoeconomics of ACE inhibitors in chronic heart failure

1 reference

12 December 2020

ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. This official ASHP practice standard was developed through the ASHP Commission on Therapeutics and approved by the ASHP Board of D

1 reference

12 December 2020

Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium

1 reference

12 December 2020

Prevalence of heart failure in three general practices in north west London

1 reference

12 December 2020

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

1 reference

12 December 2020

Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure

1 reference

12 December 2020

Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure

1 reference

12 December 2020

Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?

1 reference

12 December 2020

Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.

1 reference

12 December 2020

Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Clinical Quality Improvement Network Investigators

1 reference

12 December 2020

Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model

1 reference

12 December 2020

Trends in hospitalization for heart failure in Scotland 1980-1990.

1 reference

12 December 2020

Perspective of the pharmaceutical industry on the development of new drugs for heart failure.

1 reference

12 December 2020

A systematic review of randomized trials of disease management programs in heart failure

1 reference

12 December 2020

Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center

1 reference

12 December 2020

Is Internet-based disease management on the way?

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in heart failure: physicians' prescribing behavior.

1 reference

12 December 2020

Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure

1 reference

12 December 2020

Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages

1 reference

12 December 2020

Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.

1 reference

12 December 2020

Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Pharmacologic management of heart failure among older adults by office-based physicians in the United States

1 reference

12 December 2020

Prevalence, aetiology and management of heart failure in general practice

1 reference

12 December 2020

Improving survival for patients with advanced heart failure: A study of 737 consecutive patients

1 reference

12 December 2020

Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction

1 reference

12 December 2020

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

12 December 2020

Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure

1 reference

12 December 2020

Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure

1 reference

12 December 2020

The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice

1 reference

12 December 2020

A cost-effectiveness analysis of enalapril maleate in the management of congestive heart failure in Australia.

1 reference

12 December 2020

Changing patterns of investigation and treatment of cardiac failure in hospital

1 reference

12 December 2020

Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy

1 reference

12 December 2020

Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines

1 reference

12 December 2020

Use of echocardiography in the management of congestive heart failure in the community.

1 reference

12 December 2020

High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.

1 reference

12 December 2020

A study of the relationship between home care services and hospital readmission of patients with congestive heart failure

1 reference

12 December 2020

Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure?

1 reference

12 December 2020

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

1 reference

12 December 2020

Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study

1 reference

12 December 2020

Quality of care for elderly patients hospitalized with heart failure

1 reference

12 December 2020

Evidence of inadequate investigation and treatment of patients with heart failure

1 reference

12 December 2020

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

12 December 2020

Consensus recommendations for the management of chronic heart failure

1 reference

12 December 2020

Heart failure clinics.

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

The Natural History of Congestive Heart Failure: The Framingham Study

1 reference

12 December 2020

A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization

1 reference

12 December 2020

Factors contributing to the hospitalization of patients with congestive heart failure

1 reference

12 December 2020

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

1 reference

12 December 2020

Heart failure clinics: a possible means of improving care.

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.

1 reference

12 December 2020

Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age

1 reference

12 December 2020

Insights into the contemporary epidemiology and outpatient management of congestive heart failure

1 reference

12 December 2020

Heart failure in a district general hospital

1 reference

12 December 2020

Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics

1 reference

12 December 2020

Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic.

1 reference

12 December 2020

Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure

1 reference

12 December 2020

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

1 reference

12 December 2020

Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.

1 reference

12 December 2020

10.2165/00003495-200161140-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference